je.st
news
Home
› Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
2014-07-02 10:27:34| drugdiscoveryonline Home Page
Euroscreen, a private drug development company, announced today that its ESN364 Phase I clinical candidate, will be presented at the ICE/ENDO Meeting on Sunday, June 22nd (Chicago, IL)
Tags: the
health
present
meeting
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||